We recently showed that treatment of mice with MCC950, a selective NLRP3 inflammasome inhibitor [27], can reverse one kidney/DOCA/salt-induced hypertension in adult mice [7], implicating a role for inflammasomes in at least one form of hypertension. This evidence concerns the gene NLRP3 and hypertensive disorder.